Articles scientifiques

Investigation of the Antibacterial Properties of Silver-Doped Amorphous Carbon Coatings Produced by Low Pressure Magnetron Assisted Acetylene Discharges.

Auteurs : Job V, Laloy J, Maloteau V, Haye E, Lucas S, Penninckx S
Année : 2022
Journal : Int J Mol Sci
Volume : 23

Ovarian Clear Cell Carcinoma with Functioning Stroma and Associated Endometrial Intraepithelial Neoplasia.

Auteurs : Desimpel F, Noël JC, Verset L, Sirtaine N, Buxant F
Année : 2022
Journal : Case Rep Obstet Gynecol
Volume : 2022
Pages : 5538390

Thoracic Paravertebral Block

Auteurs : Ben Aziz M, Mukhdomi J
Année : 2022
Journal : StatPearls - Internet

Interrogating breast cancer heterogeneity using single and pooled circulating tumor cell analysis.

Auteurs : Rothé F, Venet D, Peeters D, Rouas G, Rediti M, Smeets D, Dupont F, Campbell P, Lambrechts D, Dirix L, Sotiriou C, Ignatiadis M
Année : 2022
Journal : NPJ Breast Cancer
Volume : 8
Pages : 79

Continuous ADR50 monitoring through automated linkage between endoscopy and pathology: a quality improvement initiative in a Brussels public hospital.

Auteurs : Rasschaert G, Gomez Galdon M, Vandevelde J, Eisendrath P
Année : 2022
Journal : Acta Gastroenterol Belg
Volume : 85
Pages : 259-266

Flexor digitorum profundus tendon infiltration by post-traumatic hemangioma. A pediatric case.

Auteurs : Raei A, Antoniou G, Gkotsi A, de Saint Aubain N, El Kazzi W
Année : 2022
Journal : Hand Surg Rehabil
Volume : 41
Pages : 520-522

De novo Metastatic Breast Cancer Arising in Young Women: Review of the Current Evidence.

Auteurs : Conte B, Soldato D, Razeti MG, Fregatti P, de Azambuja E, Schettini F, Prat A, Del Mastro L, Lambertini M
Année : 2022
Journal : Clin Breast Cancer
Volume : 22
Pages : 78-87

Impact of the COVID-19 Pandemic on Breast Cancer Management in Portugal: A Cross-Sectional Survey-Based Study of Medical Oncologists.

Auteurs : Alpuim Costa D, Nobre JGG, Fernandes JP, Batista MV, Simas A, Sales C, Gouveia H, Ribeiro LA, Coelho A, Brito M, Inácio M, Cruz A, Mariano M, Savva-Bordalo J, Fernandes R, Oliveira A, Chaves A, Fontes-Sousa M, Sampaio-Alves M, Martins-Branco D, Afonso N
Année : 2022
Journal : Oncol Ther
Volume : 10
Pages : 225-240

Jaundice and double-duct sign: Always cancer?

Auteurs : Lorenzo D, Verset L, Devière J
Année : 2022
Journal : Endosc Ultrasound
Volume : 11
Pages : 77-78

Optic neuritis in lung adenocarcinoma: A challenging diagnosis.

Auteurs : Goudsmit A, Brandao M, Oullai A, Engelman D, Ghorra N, Daif T, Buelens T, Meert AP
Année : 2022
Journal : Respir Med Res
Volume : 82
Pages : 100966

Use of fluorescence imaging and indocyanine green during colorectal surgery: Results of an intercontinental Delphi survey.

Auteurs : Wexner S, Abu-Gazala M, Boni L, Buxey K, Cahill R, Carus T, Chadi S, Chand M, Cunningham C, Emile SH, Fingerhut A, Foo CC, Hompes R, Ioannidis A, Keller DS, Knol J, Lacy A, de Lacy FB, Liberale G, Martz J, Mizrahi I, Montroni I, Mortensen N, Rafferty JF, Rickles AS, Ris F, Safar B, Sherwinter D, Sileri P, Stamos M, Starker P, Van den Bos J, Watanabe J, Wolf JH, Yellinek S, Zmora O, White KP, Dip F, Rosenthal RJ
Année : 2022
Journal : Surgery
Volume : 172
Pages : S38-S45

HTLV-1-related adult T-cell leukemia/lymphoma: insights in early detection and management.

Auteurs : Wolf S, Vercruyssen M, Cook L
Année : 2022
Journal : Curr Opin Oncol
Volume : 34
Pages : 446-453

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.

Auteurs : Modi S, Jacot W, Yamashita T, Sohn J, Vidal M, Tokunaga E, Tsurutani J, Ueno NT, Prat A, Chae YS, Lee KS, Niikura N, Park YH, Xu B, Wang X, Gil-Gil M, Li W, Pierga JY, Im SA, Moore HCF, Rugo HS, Yerushalmi R, Zagouri F, Gombos A, Kim SB, Liu Q, Luo T, Saura C, Schmid P, Sun T, Gambhire D, Yung L, Wang Y, Singh J, Vitazka P, Meinhardt G, Harbeck N, Cameron DA
Année : 2022
Journal : N Engl J Med
Volume : 387
Pages : 9-20

Continuing acetylsalicylic acid during Robotic-Assisted Radical Cystectomy with intracorporeal urinary diversion does not increase hemorrhagic complications: results from a large multicentric cohort.

Auteurs : Albisinni S, Diamand R, Mjaess G, Assenmacher G, Assenmacher C, Loos S, Verhoest G, Holz S, Naudin M, Ploussard G, Mari A, Di Maida F, Minervini A, Aoun F, Tay A, Issa R, Roumiguié M, Bajeot AS, Simone G, Anceschi U, Umari P, Sridhar A, Kelly J, Hendricksen K, Einerhand S, Sanchez-Salas R, Colomer A, Quackels T, Peltier A, Montorsi F, Briganti A, Pradere B, Moschini M, Roumeguère T
Année : 2022
Journal : Urol Oncol
Volume : 40
Pages : 163.e11-163.e17

The role of the intensive care unit after thoracic surgery.

Auteurs : Fontana V, Coureau M, Grigoriu B, Tamburini N, Lemaitre J, Meert AP
Année : 2022
Journal : Rev Mal Respir
Volume : 39(1)
Pages : 40-54

Hyperthermic Intraperitoneal Chemotherapy

Auteurs : Ben Aziz M, Di Napoli R
Année : 2022
Journal : StatPearls - Internet

The association between adiposity and anti-proliferative response to neoadjuvant endocrine therapy with letrozole in post-menopausal patients with estrogen receptor positive breast cancer.

Auteurs : Isnaldi E, Richard F, De Schepper M, Leduc S, Maetens M, Geukens T, Van Baelen K, Nguyen HL, Rouas G, Zoppoli G, Cardoso F, Sotiriou C, Larsimont D, Floris G, Biganzoli E, Desmedt C
Année : 2022
Journal : NPJ Breast Cancer
Volume : 8
Pages : 90

Radical Nephroureterectomy Tetrafecta: A Proposal Reporting Surgical Strategy Quality at Surgery.

Auteurs : Soria F, Pradere B, Hurle R, DAndrea D, Albisinni S, Diamand R, Laukhtina E, Di Trapani E, Aziz A, Krajewski W, Teoh JY, Mari A, Moschini M, Chiancone F, Autorino R, Porreca A, Marchioni M, Liguori G, Lucarelli G, Busetto GM, Foschi N, Antonelli A, Bove P, Russo GI, Crisan N, Borghesi M, Boeri L, Veccia A, Greco F, Longo N, De Cobelli O, Shariat SF, Gontero P, Ferro M
Année : 2022
Journal : Eur Urol Open Sci
Volume : 42
Pages : 1-8

Activin-A impairs CD8 T cell-mediated immunity and immune checkpoint therapy response in melanoma.

Auteurs : Pinjusic K, Dubey OA, Egorova O, Nassiri S, Meylan E, Faget J, Constam DB
Année : 2022
Journal : J Immunother Cancer
Volume : 10

Trastuzumab and pertuzumab without chemotherapy in early-stage HER2+ breast cancer: a plain language summary of the PHERGain study.

Auteurs : Pérez-García JM, Gebhart G, Borrego MR, Schmid P, Marmé F, Prat A, Dalenc F, Kerrou K, Colleoni M, Braga S, Malfettone A, Sampayo-Cordero M, Cortés J, Llombart-Cussac A
Année : 2022
Journal : Future Oncol
Volume : 18
Pages : 3677-3688